Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-025-01217-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823863259698036736 |
---|---|
author | Yurou Chu Biqi Zhou Rui Gao Miao Miao Huiying Qiu Xiaowen Tang Ying Wang Suning Chen Liqing Kang Depei Wu Yang Xu |
author_facet | Yurou Chu Biqi Zhou Rui Gao Miao Miao Huiying Qiu Xiaowen Tang Ying Wang Suning Chen Liqing Kang Depei Wu Yang Xu |
author_sort | Yurou Chu |
collection | DOAJ |
format | Article |
id | doaj-art-38f87b01a01c41a09da57a4def20f803 |
institution | Kabale University |
issn | 2044-5385 |
language | English |
publishDate | 2025-02-01 |
publisher | Nature Publishing Group |
record_format | Article |
series | Blood Cancer Journal |
spelling | doaj-art-38f87b01a01c41a09da57a4def20f8032025-02-09T12:13:06ZengNature Publishing GroupBlood Cancer Journal2044-53852025-02-011511410.1038/s41408-025-01217-9Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomabYurou Chu0Biqi Zhou1Rui Gao2Miao Miao3Huiying Qiu4Xiaowen Tang5Ying Wang6Suning Chen7Liqing Kang8Depei Wu9Yang Xu10National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China; Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow Universityhttps://doi.org/10.1038/s41408-025-01217-9 |
spellingShingle | Yurou Chu Biqi Zhou Rui Gao Miao Miao Huiying Qiu Xiaowen Tang Ying Wang Suning Chen Liqing Kang Depei Wu Yang Xu Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab Blood Cancer Journal |
title | Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab |
title_full | Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab |
title_fullStr | Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab |
title_full_unstemmed | Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab |
title_short | Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab |
title_sort | efficacy and safety of car t cell therapy in b all patients previously treated with blinatumomab |
url | https://doi.org/10.1038/s41408-025-01217-9 |
work_keys_str_mv | AT yurouchu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT biqizhou efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT ruigao efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT miaomiao efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT huiyingqiu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT xiaowentang efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT yingwang efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT suningchen efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT liqingkang efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT depeiwu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab AT yangxu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab |